Abstract:Research purpose: The low treatment effectiveness in major depressive disorder (MDD) may be caused by the subjectiveness in clinical examination and the lack of quantitative tests. Objective biomarkers derived from magnetic resonance imaging (MRI) may support clinical experts during decision-making. Numerous studies have attempted to identify such MRI-based biomarkers. However, the majority is uni-modal (based on a single MRI modality) and focus on either MDD diagnosis or outcome. Uncertainty remains regarding whether key features or classification models for diagnosis may also be used for outcome prediction. Therefore, we aim to find multi-modal predictors of both, MDD diagnosis and outcome. By addressing these research questions using the same dataset, we eliminate between-study confounding factors. Various structural (T1-weighted, T2-weighted, diffusion tensor imaging (DTI)) and functional (resting-state and task-based functional MRI) scans were acquired from 32 MDD and 31 healthy control (HC) subjects during the first visit at the investigational site (baseline). Depression severity was assessed at baseline and 6 months later. Features were extracted from the baseline MRI images with different modalities. Binary 6-months negative and positive outcome (NO; PO) classes were defined based on relative (to baseline) change in depression severity. Support vector machine models were employed to separate MDD from HC (diagnosis) and NO from PO subjects (outcome). Classification was performed through a uni-modal (features from a single MRI modality) and multi-modal (combination of features from different modalities) approach. Principal results: Our results show that DTI features yielded the highest uni-modal performance for diagnosis and outcome prediction: mean diffusivity (AUC (area under the curve) = 0.701) and the sum of streamline weights (AUC = 0.860), respectively. Multi-modal ensemble classifiers with T1-weighted, resting-state functional MRI and DTI features improved classification performance for both diagnosis and outcome (AUC = 0.746 and 0.932, respectively). Feature analyses revealed that the most important features were located in frontal, limbic and parietal areas. However, the modality or location of these features was different between diagnostic and prognostic models. Major conclusions: Our findings suggest that combining features from different MRI modalities predict MDD diagnosis and outcome with higher performance. Furthermore, we demonstrated that the most important features for MDD diagnosis were different and located in other brain regions than those for outcome. This longitudinal study contributes to the identification of objective biomarkers of MDD and its outcome. Follow-up studies may further evaluate the generalizability of our models in larger or multi-center cohorts.

Research Progress of Biological Markers for Depression Based on Psychoradiology and Artificial Intelligence

The Role of Magnetic Resonance Imaging in Predicting the Efficacy of Depression

Translational Application of Neuroimaging in Major Depressive Disorder: a Review of Psychoradiological Studies

Research progress in depression related biomarkers based on omics technology

Promising Neuroimaging Biomarkers in Depression

Resting-State Functional Magnetic Resonance Image to Analyze Electrical Biological Characteristics of Major Depressive Disorder Patients with Suicide Ideation

Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression

AI Machine Learning Technique Characterizes Potential Markers of Depression in Two Animal Models of Depression

Artificial Intelligence Applications in Psychoradiology

Advances in biosensors for major depressive disorder diagnostic biomarkers

Mapping the structure of depression biomarker research: A bibliometric analysis

Machine learning in major depression: From classification to treatment outcome prediction

Neuroimaging Advance in Depressive Disorder.

Research progress of deep learning algorithm in the auxiliary diagnosis of depression based on behavior analysis

Research progress of magnetic resonance imaging in major depressive disorder

Progress in neuroimaging related to suicide in depression

Sleep Disturbance-Related Neuroimaging Features As Potential Biomarkers for the Diagnosis of Major Depressive Disorder: A Multicenter Study Based on Machine Learning

Multi-modal MRI for objective diagnosis and outcome prediction in depression

Research progress of functional magnetic resonance imaging in self-referential processing of depression

Neuroimage Analysis Methods and Artificial Intelligence Techniques for Reliable Biomarkers and Accurate Diagnosis of Schizophrenia: Achievements Made by Chinese Scholars Around the Past Decade

The Role of Neuroimaging in the Diagnosis and Treatment of Depressive Disorder: A Recent Review.